IMNM R&D Expenses

Immunome Inc · R&D Expenses

IMNM logo

IMNM R&D Expenses

Latest reported$216.23M
IMNM TTM R&D Expenses ($8.82M → $216.23M)
High-resolution chart · PNG

IMNM r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Immunome Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
216,229,000
196,795,000
187,286,000
174,406,000
162,413,000
151,045,000
129,542,000
91,289,000
57,912,000
34,545,000
23,089,000
17,704,000
19,106,000
19,107,000
23,272,000
23,405,000
22,693,000
20,209,000
14,110,000
11,560,000
8,691,000
7,350,000
7,486,000
8,083,000
8,673,000
8,859,500
8,823,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.